HCV治疗完成是否会影响阿片类激动剂维持治疗患者的神经认知结局：一项次要分析。

IF 1.7 4区医学 Q3 PSYCHIATRY

Indian Journal of Psychiatry Pub Date : 2025-02-01 Epub Date: 2025-02-19 DOI:10.4103/indianjpsychiatry.indianjpsychiatry_900_24

Abhishek Ghosh, Abhishek Verma, Arka De, Madhumita Premkumar, Ajay Duseja, Ritu Nehra, Debasish Basu

{"title":"HCV治疗完成是否会影响阿片类激动剂维持治疗患者的神经认知结局：一项次要分析。","authors":"Abhishek Ghosh, Abhishek Verma, Arka De, Madhumita Premkumar, Ajay Duseja, Ritu Nehra, Debasish Basu","doi":"10.4103/indianjpsychiatry.indianjpsychiatry_900_24","DOIUrl":null,"url":null,"abstract":"Aim: This secondary analysis investigated whether completing Direct-Acting Antiviral (DAA) treatment affects neurocognitive outcomes in patients with opioid use disorder (OUD) undergoing opioid agonist maintenance treatment (OAMT).Methods: Data from 45 participants (22 DAA treatment completers and 23 non-completers) were analyzed. Neurocognitive function was assessed at baseline and six months using the Wisconsin Card Sorting Test (WCST), Trail Making Tests (TMT A and B), Visual and Verbal N-Back tests, and Iowa Gambling Task (IGT).Results: General Linear Model (GLM) analysis revealed significant improvements in cognitive function over time in both groups, with notable gains in WCST total correct responses (P < .001) and Visual Working Memory 2 Back hits and errors (P < .001). A significant Group × Time was found for TMT-B completion time, with non-completers showing greater improvement (P = .039).Conclusion: These findings highlight that even incomplete DAA treatment, alongside OAMT, yields significant cognitive benefits, underscoring the importance of integrated care.","PeriodicalId":13345,"journal":{"name":"Indian Journal of Psychiatry","volume":"67 2","pages":"260-266"},"PeriodicalIF":1.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964169/pdf/","citationCount":"0","resultStr":"{\"title\":\"Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis.\",\"authors\":\"Abhishek Ghosh, Abhishek Verma, Arka De, Madhumita Premkumar, Ajay Duseja, Ritu Nehra, Debasish Basu\",\"doi\":\"10.4103/indianjpsychiatry.indianjpsychiatry_900_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: This secondary analysis investigated whether completing Direct-Acting Antiviral (DAA) treatment affects neurocognitive outcomes in patients with opioid use disorder (OUD) undergoing opioid agonist maintenance treatment (OAMT).Methods: Data from 45 participants (22 DAA treatment completers and 23 non-completers) were analyzed. Neurocognitive function was assessed at baseline and six months using the Wisconsin Card Sorting Test (WCST), Trail Making Tests (TMT A and B), Visual and Verbal N-Back tests, and Iowa Gambling Task (IGT).Results: General Linear Model (GLM) analysis revealed significant improvements in cognitive function over time in both groups, with notable gains in WCST total correct responses (P < .001) and Visual Working Memory 2 Back hits and errors (P < .001). A significant Group × Time was found for TMT-B completion time, with non-completers showing greater improvement (P = .039).Conclusion: These findings highlight that even incomplete DAA treatment, alongside OAMT, yields significant cognitive benefits, underscoring the importance of integrated care.\",\"PeriodicalId\":13345,\"journal\":{\"name\":\"Indian Journal of Psychiatry\",\"volume\":\"67 2\",\"pages\":\"260-266\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964169/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_900_24\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_900_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

摘要

目的：这项二次分析调查了完成直接作用抗病毒药物（DAA）治疗是否会影响接受阿片激动剂维持治疗（OAMT）的阿片类药物使用障碍（OUD）患者的神经认知结果：分析了45名参与者（22名完成DAA治疗者和23名未完成治疗者）的数据。在基线和6个月时，使用威斯康星卡片分类测试（WCST）、路径制作测试（TMT A和B）、视觉和言语N-Back测试以及爱荷华赌博任务（IGT）对神经认知功能进行评估：通用线性模型（GLM）分析表明，随着时间的推移，两组患者的认知功能都有显著改善，其中 WCST 总正确率（P < .001）和视觉工作记忆 2 回的命中率和错误率（P < .001）显著提高。在 TMT-B 完成时间方面，发现了明显的组别 × 时间关系，未完成者的进步更大（P = .039）：这些研究结果表明，即使是不完全的 DAA 治疗，与 OAMT 同时进行，也能产生显著的认知益处，从而强调了综合护理的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Does HCV treatment completion affect the neurocognitive outcomes in patients on opioid agonist maintenance treatment: A secondary analysis.

Aim: This secondary analysis investigated whether completing Direct-Acting Antiviral (DAA) treatment affects neurocognitive outcomes in patients with opioid use disorder (OUD) undergoing opioid agonist maintenance treatment (OAMT).

Methods: Data from 45 participants (22 DAA treatment completers and 23 non-completers) were analyzed. Neurocognitive function was assessed at baseline and six months using the Wisconsin Card Sorting Test (WCST), Trail Making Tests (TMT A and B), Visual and Verbal N-Back tests, and Iowa Gambling Task (IGT).

Results: General Linear Model (GLM) analysis revealed significant improvements in cognitive function over time in both groups, with notable gains in WCST total correct responses (P < .001) and Visual Working Memory 2 Back hits and errors (P < .001). A significant Group × Time was found for TMT-B completion time, with non-completers showing greater improvement (P = .039).

Conclusion: These findings highlight that even incomplete DAA treatment, alongside OAMT, yields significant cognitive benefits, underscoring the importance of integrated care.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Indian Journal of Psychiatry Medicine-Psychiatry and Mental Health

CiteScore

4.40

自引率

3.20%

发文量

130

审稿时长

34 weeks

期刊介绍： The Indian Journal of Psychiatry (ISSN 0019-5545), is an official publication of the Indian Psychiatric Society. It is published Bimonthly with one additional supplement (total 5 issues). The IJP publishes original work in all the fields of psychiatry. All papers are peer-reviewed before publication. The issues are published Bimonthly. An additional supplement is also published annually. Articles can be submitted online from www.journalonweb.com . The journal provides immediate free access to all the published articles. The journal does not charge the authors for submission, processing or publication of the articles.